Education:
• BS, Cornell University, Ithaca, NY
• PhD, Weill Cornell Graduate School of Medical Sciences, New York, NY

Previous Institutions:
• Sloan Kettering Institute – Postdoctoral Fellowship
• Weill Cornell Graduate School of Medical Sciences – PhD

Dr. Blawski’s interests are identifying epigenetic mechanisms of therapy resistance in breast cancer with a focus on protein methylation

rblawsk1@jhmi.edu

Education:

• BS, Mathematics and applied mathematics, Renmin University of China, Beijing, China
• ScM (transferred), Biostatistics, Johns Hopkins University, Baltimore, MD

Wanlu is interested in developing statistical and computational methods for analyzing genomic data and applying them to study gene regulatory problems.

wchen111@jhmi.edu

Education: BS (Biotechnology, Chemistry, Zoology), CHRIST University, India

Tiana is interested in studying the mechanisms and regulation of epigenetic factors that influence cancer progression.

Education:

• BE, Biotechnology, Siddaganga Institute of Technology, India
• MS, Biotechnology, New York University, New York
• PhD, Biochemistry and Molecular Biology (2026), Johns Hopkins Bloomberg School of Public Health

Previous Institution:
Memorial Sloan Kettering Cancer Center (New York), New York University (New York)

Srushti’s interest lies in studying the mechanism of action of epigenetic genes and their regulation of the processes that influence cancer etiology and therapeutic intervention.

skittan1@jhmi.edu

Education:

• BS Biotechnology – Iowa State University, Ames IA
• Minor in Computer Science – PES University, Bangalore, India
• MS Bioinformatics – Johns Hopkins University, Baltimore MD

Previous Institutions:

• The Nanovaccine Institute, Ames, IA
• Sidney Kimmel Cancer Center, Baltimore MD

Rachana’s research interests center on understanding how chromatin and epigenetic regulation drive resistance to endocrine therapy in estrogen receptor-positive (ER+) breast cancer, using genomic approaches to identify new therapeutic vulnerabilities.

Education:

• ScM, Biochemistry and Molecular Biology (2023), Johns Hopkins Bloomberg School of Public Health
• Tech, Biotechnology (2021), SRM Institute of Science and Technology

Pranav is interested in understanding the role of mutant histones that correlate to chemotherapeutic resistance in Uterine Carcinosarcoma.

pshivas1@jh.edu

Education:  BS Molecular, Cellular and Developmental Biology, University of Washington

Jun is interested in in how dysregulated epigenetic regulators, such as histone methyltransferases, drive resistance to therapy in breast cancer.

Education:

• BSc, Biomedical Informatics (2025), Zhejiang University
• BSc, Biomedical Informatics (2025), University of Edinburgh

Huanchang is interested in developing and applying statistical and machine learning methods to investigate gene regulation and the molecular mechanisms underlying human diseases.

htu7@jh.edu

Education:
BS, Biochemistry, Virginia Tech, VA

Previous Institution:
Fralin Life Sciences Institute, Blacksburg, VA

Bryce’s research interests are focused on understanding the way epigenetic regulators influence metastatic progression and therapy resistances in breast cancer.

bwoznia1@jh.edu

Education: BS, Biochemistry, Presbyterian College, Clinton, South Carolina

Previous Institutions: Frederick National Laboratory

Megan is focused on elucidating how epigenetic dysregulation contributes to cancer progression and therapeutic resistance, with the goal of identifying potential clinical interventions.

Current PhD student at UC, San Diego